BDX Becton, Dickinson and Company
Healthcare$147.75+0.08%ClosedMarket Cap: $53.53B
As of 2026-05-26
Valuation
P/E (TTM)
31.80
PEG
18.31
P/B
1.72
P/S
2.50
EV/EBITDA
16.80
DCF Value
$1,124.36
FCF Yield
5.9%
Div Yield
2.4%
Margins & Returns
Gross Margin
46.5%
Operating Margin
10.6%
Net Margin
5.3%
ROE
4.5%
ROA
2.2%
ROIC
4.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $4.71B | 45.7% | $94.0M | $-311.0M | $— | $1.05 |
| Q1 null | $5.25B | 44.6% | $594.0M | $382.0M | $— | $1.05 |
| Q4 null | $5.89B | 47.5% | $697.0M | $493.0M | $— | $1.04 |
| FY null | $21.84B | 45.4% | $2.58B | $1.68B | $— | $4.16 |
| Q3 null | $5.51B | 47.8% | $882.0M | $574.0M | $— | $1.04 |
| Q2 null | $5.27B | 42.8% | $546.0M | $308.0M | $— | $1.04 |
| Q1 null | $5.17B | 43.2% | $453.0M | $303.0M | $— | $1.04 |
| Q4 null | $5.44B | 45.7% | $622.0M | $400.0M | $— | $0.95 |
| FY null | $20.18B | 45.2% | $2.40B | $1.71B | $— | $3.80 |
| Q3 null | $4.99B | 46.2% | $602.0M | $487.0M | $— | $0.95 |
| Q2 null | $5.04B | 45.7% | $734.0M | $537.0M | $— | $0.95 |
| Q1 2024 | $4.71B | 43.1% | $439.0M | $281.0M | $0.96 | $0.95 |